| Overview |
| bsm-62504r-Cy5.5-100ul |
| RCL Recombinant Antibody, Cy5.5 Conjugated |
| WB, IF |
| Human |
| Specifications |
| Cy5.5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human c Myc responsive protein RCL |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 10591 |
| O43598 |
| Cytoplasm, Nucleus |
| DNPH1; Rcl. |
| Part of a nucleotide salvage pathway that eliminates epigenetically modified 5-hydroxymethyl-dCMP (hmdCMP) in a two-step process entailing deamination to cytotoxic 5-hydroxymethyl-dUMP (hmdUMP), followed by its hydrolysis into 5-hydroxymethyluracil (hmU) and 2-deoxy-D-ribose 5-phosphate (deoxyribosephosphate). |
| Application Dilution |
| WB |
1:300-5000 |
| IF |
|
Powered by Bioz